Deutsche Bank’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$643K Buy
6,684
+805
+14% +$80.5K ﹤0.01% 2448
2025
Q4
$572K Buy
5,879
+577
+11% +$49.5K ﹤0.01% 2497
2025
Q3
$377K Hold
5,302
﹤0.01% 2697
2025
Q2
$317K Hold
5,302
﹤0.01% 2696
2025
Q1
$278K Hold
5,302
﹤0.01% 2794
2024
Q4
$292K Hold
5,302
﹤0.01% 2932
2024
Q3
$267K Buy
5,302
+1,376
+35% +$63.5K ﹤0.01% 2777
2024
Q2
$173K Sell
3,926
-232
-6% -$9.87K ﹤0.01% 2886
2024
Q1
$183K Buy
4,158
+239
+6% +$10.6K ﹤0.01% 2873
2023
Q4
$186K Sell
3,919
-58
-1% -$2.44K ﹤0.01% 2921
2023
Q3
$176K Buy
3,977
+563
+16% +$26.2K ﹤0.01% 2862
2023
Q2
$163K Sell
3,414
-1,222
-26% -$55.1K ﹤0.01% 3008
2023
Q1
$182K Buy
4,636
+1,324
+40% +$48.1K ﹤0.01% 3050
2022
Q4
$93.7K Buy
3,312
+50
+2% +$1.43K ﹤0.01% 3359
2022
Q3
$98K Buy
3,262
+79
+2% +$2.75K ﹤0.01% 3328
2022
Q2
$108K Sell
3,183
-381
-11% -$13.7K ﹤0.01% 3491
2022
Q1
$160K Sell
3,564
-407
-10% -$18.8K ﹤0.01% 3379
2021
Q4
$183K Buy
3,971
+190
+5% +$7.67K ﹤0.01% 3431
2021
Q3
$127K Sell
3,781
-55
-1% -$1.87K ﹤0.01% 3792
2021
Q2
$113K Sell
3,836
-122
-3% -$3.36K ﹤0.01% 4088
2021
Q1
$102K Sell
3,958
-360
-8% -$8.6K ﹤0.01% 3972
2020
Q4
$98K Buy
4,318
+1,237
+40% +$28.6K ﹤0.01% 3853
2020
Q3
$66K Buy
3,081
+292
+10% +$6.56K ﹤0.01% 3744
2020
Q2
$65K Buy
2,789
+1,258
+82% +$27K ﹤0.01% 3676
2020
Q1
$33K Sell
1,531
-2,791
-65% -$66.5K ﹤0.01% 3733
2019
Q4
$100K Buy
4,322
+2,088
+93% +$48.8K ﹤0.01% 3581
2019
Q3
$44K Sell
2,234
-1,317
-37% -$26.9K ﹤0.01% 4001
2019
Q2
$70K Sell
3,551
-1,367
-28% -$32.2K ﹤0.01% 4365
2019
Q1
$136K Buy
4,918
+324
+7% +$8.48K ﹤0.01% 4193
2018
Q4
$111K Sell
4,594
-3,345
-42% -$89.9K ﹤0.01% 4173
2018
Q3
$295K Sell
7,939
-35,131
-82% -$948K ﹤0.01% 4057
2018
Q2
$893K Buy
43,070
+26,454
+159% +$468K ﹤0.01% 3506
2018
Q1
$238K Sell
16,616
-6,484
-28% -$92.3K ﹤0.01% 4095
2017
Q4
$349K Buy
23,100
+20,590
+820% +$262K ﹤0.01% 3777
2017
Q3
$24K Sell
2,510
-2,164
-46% -$20.5K ﹤0.01% 4533
2017
Q2
$40K Buy
4,674
+135
+3% +$1.15K ﹤0.01% 4422
2017
Q1
$39K Sell
4,539
-2,198
-33% -$20.4K ﹤0.01% 4301
2016
Q4
$73K Sell
6,737
-13,951
-67% -$150K ﹤0.01% 4217
2016
Q3
$350K Buy
20,688
+15,370
+289% +$285K ﹤0.01% 3370
2016
Q2
$115K Buy
5,318
+210
+4% +$3.78K ﹤0.01% 4037
2016
Q1
$97K Buy
5,108
+1,614
+46% +$30.9K ﹤0.01% 4034
2015
Q4
$96K Sell
3,494
-86
-2% -$2.43K ﹤0.01% 4078
2015
Q3
$87K Buy
3,580
+106
+3% +$2.54K ﹤0.01% 4167
2015
Q2
$80K Buy
3,474
+1,254
+56% +$22.9K ﹤0.01% 4348
2015
Q1
$33K Buy
+2,220
New +$32.8K ﹤0.01% 4509

Other funds holding IRMD

Deutsche Bank's IRMD Position: Q1 2026 in Review

Deutsche Bank increased its iRadimed (IRMD) stake by 14% in Q1 2026, buying an estimated $80.5K and bringing the position to 6,684 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #2448.

Deutsche Bank first reported a position in IRMD in Q1 2015 and has held it in 45 quarters since. The position peaked at $893K in Q2 2018. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Deutsche Bank held 6,684 shares of iRadimed worth $643K as of Q1 2026.
  • Deutsche Bank bought 805 iRadimed shares in Q1 2026, an estimated $80.5K.
  • iRadimed made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2448 holding.
  • Deutsche Bank first reported a position in iRadimed in Q1 2015 and has held it in 45 quarters since.
  • Deutsche Bank's iRadimed position peaked at $893K in Q2 2018.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.